Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

ConditionChronic Myeloid Leukemia

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorAssiut University

About this trial

to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism

Eligibility criteria

Qualifiers

CML patients free medical history

Disqualifiers

diabetic

Trial design

Treatments tested in this trial

Tyrosine kinase Inhibitors (Imatinib & Nilotinib)